@article{10.37349/edd.2025.100589,
abstract = {Amyloidosis is a rare disease, corresponding to a deposition of proteins in various tissues. Amyloid light-chain (AL) amyloidosis can involve the liver in 17% to 45% of patients. Diagnosis of liver disease is based on specific criteria, coupling alkaline phosphatases and hepatomegaly. Liver stiffness is altered in cases of heart involvement, and overall, in cases of liver involvement. Liver biopsy is generally avoided due to an important bleeding risk. Treatment is essentially based on stem cell transplantation and chemotherapy, with large progress during the last decade. Liver involvement recovery is generally diagnosed with a reduction in alkaline phosphatases and in liver size.},
author = {Carrier, Paul and Debette-Gratien, Marilyne and Abraham, Julie and Cypierre, Anne and Cadranel, Jean-François and Jaccard, Arnaud and Loustaud-Ratti, Véronique},
doi = {10.37349/edd.2025.100589},
journal = {Exploration of Digestive Diseases},
elocation-id = {100589},
title = {Amyloidosis and liver. Review.},
url = {https://www.explorationpub.com/Journals/edd/Article/100589},
volume = {4},
year = {2025}
}